Published in PLoS One on June 30, 2008
Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol (2010) 2.86
Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma. Nat Genet (2009) 2.73
Genetic architecture of microRNA expression: implications for the transcriptome and complex traits. Am J Hum Genet (2012) 1.36
A generic coalescent-based framework for the selection of a reference panel for imputation. Genet Epidemiol (2010) 1.26
Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16-associated head and neck cancer. Carcinogenesis (2009) 1.13
Human genetic variation influences vitamin C homeostasis by altering vitamin C transport and antioxidant enzyme function. Annu Rev Nutr (2013) 1.02
Association of HLA-DQB1 alleles with risk of follicular lymphoma. Leuk Lymphoma (2010) 0.94
Hormonal and sex impact on the epidemiology of canine lymphoma. J Cancer Epidemiol (2010) 0.92
The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma. Genes Immun (2011) 0.92
Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma. Biomarkers (2009) 0.91
PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium. Blood (2012) 0.89
Association of the polymorphisms of MMP-9 and TIMP-3 genes with thoracic aortic dissection in Chinese Han population. Acta Pharmacol Sin (2014) 0.87
Regulation of the Epigenome by Vitamin C. Annu Rev Nutr (2015) 0.87
A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region. Cancer Epidemiol Biomarkers Prev (2012) 0.86
A meta-analysis of genome-wide association studies of follicular lymphoma. BMC Genomics (2012) 0.85
Chemokine polymorphisms and lymphoma: a pooled analysis. Leuk Lymphoma (2010) 0.84
Vitamin C transporter gene (SLC23A1 and SLC23A2) polymorphisms, plasma vitamin C levels, and gastric cancer risk in the EPIC cohort. Genes Nutr (2013) 0.83
The epigenetic role of vitamin C in health and disease. Cell Mol Life Sci (2016) 0.83
Dietary acrylamide intake and the risk of lymphatic malignancies: the Netherlands Cohort Study on diet and cancer. PLoS One (2012) 0.81
Host genetics in follicular lymphoma. Best Pract Res Clin Haematol (2011) 0.79
Genetic Variation in Human Vitamin C Transporter Genes in Common Complex Diseases. Adv Nutr (2016) 0.79
ESR1 single nucleotide polymorphisms predict breast cancer susceptibility in the central European Caucasian population. Int J Clin Exp Med (2013) 0.79
Single nucleotide polymorphisms of matrix metalloproteinase 9 (MMP9) and tumor protein 73 (TP73) interact with Epstein-Barr virus in chronic lymphocytic leukemia: results from the European case-control study EpiLymph. Haematologica (2010) 0.78
Genetic polymorphisms in SLC23A2 as predictive biomarkers of severe acute toxicities after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma. Int J Med Sci (2014) 0.77
A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival. BMC Med Genet (2014) 0.76
Fruit and vegetable intake and vitamin C transporter gene (SLC23A2) polymorphisms in chronic lymphocytic leukaemia. Eur J Nutr (2016) 0.76
Non-Hodgkin lymphoma risk and variants in genes controlling lymphocyte development. PLoS One (2013) 0.75
Ascorbate availability affects tumor implantation-take rate and increases tumor rejection in Gulo(-/-) mice. Hypoxia (Auckl) (2016) 0.75
Sex- and subtype-specific analysis of H2AFX polymorphisms in non-Hodgkin lymphoma. PLoS One (2013) 0.75
The potential relevance of the endocannabinoid, 2-arachidonoylglycerol, in diffuse large B-cell lymphoma. Oncoscience (2016) 0.75
Vitamin C Transporters in Cancer: Current Understanding and Gaps in Knowledge. Front Oncol (2017) 0.75
Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23
dbSNP: the NCBI database of genetic variation. Nucleic Acids Res (2001) 76.97
The International HapMap Project. Nature (2003) 73.65
A new statistical method for haplotype reconstruction from population data. Am J Hum Genet (2001) 59.30
Human non-synonymous SNPs: server and survey. Nucleic Acids Res (2002) 50.45
Database resources of the National Center for Biotechnology Information: 2002 update. Nucleic Acids Res (2002) 19.40
Predictive identification of exonic splicing enhancers in human genes. Science (2002) 16.86
Statistical methods in cancer research. Volume I - The analysis of case-control studies. IARC Sci Publ (1980) 15.47
ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res (2003) 12.81
Ensembl 2002: accommodating comparative genomics. Nucleic Acids Res (2003) 12.26
dbSNP: a database of single nucleotide polymorphisms. Nucleic Acids Res (2000) 6.84
Haplotype reconstruction from genotype data using Imperfect Phylogeny. Bioinformatics (2004) 6.02
FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res (2006) 5.60
Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies. Am J Hum Genet (2004) 4.51
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol (2006) 4.13
The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer (2007) 3.44
SNPper: retrieval and analysis of human SNPs. Bioinformatics (2002) 3.30
Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol (2000) 3.13
Ascorbic-acid transporter Slc23a1 is essential for vitamin C transport into the brain and for perinatal survival. Nat Med (2002) 2.90
Matrix metalloproteinases in tumour invasion and metastasis. J Pathol (1999) 2.65
Vitamin C. Biosynthesis, recycling and degradation in mammals. FEBS J (2007) 2.55
Pyrosequencing: an accurate detection platform for single nucleotide polymorphisms. Hum Mutat (2002) 2.36
Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents. Am J Pathol (2006) 2.21
Genetic susceptibility to lymphoma. Haematologica (2007) 2.03
Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood (2004) 1.93
Body mass index, leptin and leptin receptor polymorphisms, and non-hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev (2004) 1.80
Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am J Epidemiol (1999) 1.80
SVCT1 and SVCT2: key proteins for vitamin C uptake. Amino Acids (2007) 1.67
Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin's lymphoma. Haematologica (2006) 1.64
Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene (1992) 1.40
Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control (2006) 1.38
Prior history of allergies and pancreatic cancer in the San Francisco Bay area. Am J Epidemiol (2003) 1.38
A hidden Markov modeling approach for admixture mapping based on case-control data. Genet Epidemiol (2004) 1.36
Non-Hodgkin's lymphoma, obesity and energy homeostasis polymorphisms. Br J Cancer (2005) 1.33
Dietary factors and risk of non-hodgkin lymphoma in men and women. Cancer Epidemiol Biomarkers Prev (2005) 1.29
Obesity, diet and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev (2007) 1.26
Role of estrogen receptor alpha in hematopoietic stem cell development and B lymphocyte maturation in the male mouse. Endocrinology (2000) 1.22
Food groups and risk of non-Hodgkin lymphoma: a multicenter, case-control study in Italy. Int J Cancer (2006) 1.21
Population-based study of lymphoma in Germany: rationale, study design and first results. Leuk Res (2004) 1.19
Polarized localization of vitamin C transporters, SVCT1 and SVCT2, in epithelial cells. Biochem Biophys Res Commun (2005) 1.19
Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma. Br J Haematol (2006) 1.16
Reproductive factors and risk of intermediate- or high-grade B-Cell non-Hodgkin's lymphoma in women. J Clin Oncol (2001) 1.15
Non-Hodgkin lymphoma in women: reproductive factors and exogenous hormone use. Am J Epidemiol (2008) 1.08
Gender and sodium-ascorbate transporter isoforms determine ascorbate concentrations in mice. J Nutr (2004) 1.07
Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes. Cancer Epidemiol Biomarkers Prev (2005) 1.06
Regulation of aromatase promoter activity in human breast tissue by nuclear receptors. Oncogene (2002) 1.05
Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin lymphoma. Cancer Causes Control (2007) 1.04
Polymorphisms and haplotypes in the cytochrome P450 17A1, prolactin, and catechol-O-methyltransferase genes and non-Hodgkin lymphoma risk. Cancer Epidemiol Biomarkers Prev (2005) 1.00
Statin use and risk of lymphoid neoplasms: results from the European Case-Control Study EPILYMPH. Cancer Epidemiol Biomarkers Prev (2006) 0.99
The association of bone mineral density with estrogen receptor gene polymorphisms. Am J Med (2006) 0.98
Hematopoietic cancer and angiogenesis. Stem Cells Dev (2004) 0.94
Lymphoma and the control of B cell growth and differentiation. Curr Mol Med (2006) 0.92
Haplotype analysis of the estrogen receptor 1 gene in male genital and reproductive abnormalities. Hum Reprod (2007) 0.92
Combined estrogen receptor alpha and estrogen receptor beta genotypes influence the age of menarche. Hum Reprod (2005) 0.90
Investigation of the estrogen receptor-alpha gene with type 2 diabetes and/or nephropathy in African-American and European-American populations. Diabetes (2007) 0.90
Biological role of vitamin C in keratinocytes. Nutr Rev (2005) 0.89
Online resources for SNP analysis: a review and route map. Mol Biotechnol (2007) 0.89
Ascorbic acid induces apoptosis in adult T-cell leukemia. Anticancer Res (2007) 0.88
Polymorphisms in ghrelin and neuropeptide Y genes are associated with non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev (2005) 0.88
Polymorphisms in cytochrome P450 17A1 and risk of non-Hodgkin lymphoma. Br J Haematol (2005) 0.88
World Health Organization Classification of lymphomas: a work in progress. Ann Oncol (1998) 0.85
HMG CoA reductase inhibitors (statins) to treat Epstein-Barr virus-driven lymphoma. Br J Cancer (2005) 0.84
Ascorbate peroxidase, a scavenger of hydrogen peroxide in glyoxysomal membranes. Arch Biochem Biophys (2005) 0.81
Gelatinases (MMP-2 and MMP-9), TIMP-1 expression and the extent of neovascularization in aggressive non-Hodgkin's lymphomas. Eur J Haematol (2003) 0.79
Studies on the mechanism of estrogen biosynthesis in the rat ovary--I. J Steroid Biochem (1976) 0.78
Estrogen receptor in the "non-lymphocytes" in the thymus of the ovariectomized rat. Tokai J Exp Clin Med (1983) 0.78
[Hepatitis B: infective agent, infection transmission, infection recipient]. Sykepleien (1976) 0.77
Population genomics of human gene expression. Nat Genet (2007) 24.49
Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science (2007) 23.38
Whole-genome patterns of common DNA variation in three human populations. Science (2005) 21.22
Genome-wide associations of gene expression variation in humans. PLoS Genet (2005) 17.27
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
A comparison of phasing algorithms for trios and unrelated individuals. Am J Hum Genet (2006) 12.45
Identifying personal genomes by surname inference. Science (2013) 10.79
Estimating local ancestry in admixed populations. Am J Hum Genet (2008) 5.90
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. N Engl J Med (2015) 5.03
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89
Effect of reduction in household air pollution on childhood pneumonia in Guatemala (RESPIRE): a randomised controlled trial. Lancet (2011) 4.79
Epidemiology. Environment and disease risks. Science (2010) 4.64
Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst (2005) 4.45
Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood (2008) 4.41
Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis (2003) 4.41
Hematotoxicity in workers exposed to low levels of benzene. Science (2004) 4.19
Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst (2006) 4.17
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol (2006) 4.13
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood (2008) 3.81
Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp. Am J Trop Med Hyg (2003) 3.71
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Leveraging the HapMap correlation structure in association studies. Am J Hum Genet (2007) 3.57
Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet (2003) 3.53
Accounting for haplotype uncertainty in matched association studies: a comparison of simple and flexible techniques. Genet Epidemiol (2005) 3.44
Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: A Genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controls. Circ Cardiovasc Genet (2010) 3.15
Inhibition of activated pericentromeric SINE/Alu repeat transcription in senescent human adult stem cells reinstates self-renewal. Cell Cycle (2011) 3.11
Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol (2010) 2.86
Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma. Nat Genet (2009) 2.73
Genomic privacy and limits of individual detection in a pool. Nat Genet (2009) 2.60
Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS (2005) 2.56
Inference of locus-specific ancestry in closely related populations. Bioinformatics (2009) 2.54
Toward understanding the risk of secondary airborne infection: emission of respirable pathogens. J Occup Environ Hyg (2005) 2.48
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet (2010) 2.37
Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe. AIDS (2007) 2.35
Occupational exposure to formaldehyde, hematotoxicity, and leukemia-specific chromosome changes in cultured myeloid progenitor cells. Cancer Epidemiol Biomarkers Prev (2010) 2.34
Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. Int J Epidemiol (2009) 2.32
Fast and accurate inference of local ancestry in Latino populations. Bioinformatics (2012) 2.30
On the inference of ancestries in admixed populations. Genome Res (2008) 2.27
Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol (2005) 2.27
Estimating the effects of potential public health interventions on population disease burden: a step-by-step illustration of causal inference methods. Am J Epidemiol (2009) 2.24
Environmental change and infectious disease: how new roads affect the transmission of diarrheal pathogens in rural Ecuador. Proc Natl Acad Sci U S A (2006) 2.23
Nucleic acid amplification tests in the diagnosis of tuberculous pleuritis: a systematic review and meta-analysis. BMC Infect Dis (2004) 2.17
An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Environ Health Perspect (2010) 2.16
Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers. Integr Cancer Ther (2006) 2.15
Biological sample collection and processing for molecular epidemiological studies. Mutat Res (2003) 2.13
Identifying individuals at high risk of melanoma: a practical predictor of absolute risk. J Clin Oncol (2006) 2.05
Diet and melanoma in a case-control study. Cancer Epidemiol Biomarkers Prev (2004) 2.05
Genetic susceptibility to lymphoma. Haematologica (2007) 2.03
Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer (2008) 2.02
A model-based approach for analysis of spatial structure in genetic data. Nat Genet (2012) 2.02
Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer (2008) 2.01
Leveraging genetic variability across populations for the identification of causal variants. Am J Hum Genet (2010) 2.00
Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. J Natl Cancer Inst (2012) 1.99
Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic. J Infect Dis (2011) 1.98
Efficient reconstruction of haplotype structure via perfect phylogeny. J Bioinform Comput Biol (2003) 1.96
An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge. Genome Biol (2014) 1.95
Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood (2004) 1.93